Legacy Capital Group California’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $766K | Sell |
11,103
-3,177
| -22% | -$219K | 0.21% | 123 |
|
|
2025
Q1 | $992K | Buy |
14,280
+7,778
| +120% | +$540K | 0.35% | 61 |
|
|
2024
Q4 | $559K | Sell |
6,502
-1,108
| -15% | -$95.3K | 0.17% | 158 |
|
|
2024
Q3 | $906K | Sell |
7,610
-6,999
| -48% | -$833K | 0.3% | 89 |
|
|
2024
Q2 | $2.09M | Sell |
14,609
-669
| -4% | -$95.5K | 0.75% | 21 |
|
|
2024
Q1 | $1.96M | Sell |
15,278
-235
| -2% | -$30.2K | 0.72% | 22 |
|
|
2023
Q4 | $1.6M | Sell |
15,513
-483
| -3% | -$50K | 0.62% | 26 |
|
|
2023
Q3 | $1.45M | Buy |
15,996
+9,044
| +130% | +$822K | 0.62% | 26 |
|
|
2023
Q2 | $563K | Buy |
6,952
+2,688
| +63% | +$218K | 0.23% | 130 |
|
|
2023
Q1 | $339K | Buy |
+4,264
| New | +$339K | 0.17% | 175 |
|